Turret Capital
Overview
Turret Capital is a global biomedical investment and venture-building company that focuses on early-stage investments. Headquartered in New York with a presence in Asia, the firm's mission is to elevate global healthcare standards through company creation, investments, and cross-border strategies, particularly between the US and Asia. It identifies as a venture builder and is also classified as an accelerator/incubator, with a focus on healthcare and medical technologies.
Portfolio Companies
4
Website
turretfunds.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Onego Bio | Apr 2024 | Series A | Co-investor |
| Sable Bio | Feb 2026 | Seed | Co-investor |
| Milu Labs | Mar 2019 | Seed | Co-investor |
| Egret Therapeutics | Feb 2022 | Seed | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Turret Capital based?
Turret Capital is headquartered in New York City, New York, United States.
When was Turret Capital founded?
Founding year information for Turret Capital is not publicly available.
How many portfolio companies does Turret Capital have?
Turret Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Turret Capital's portfolio?
Portfolio companies visible on Caplight include Onego Bio, Sable Bio, Milu Labs, Egret Therapeutics.
What was Turret Capital's most recent investment shown here?
Turret Capital's most recent investment in this portfolio sample was in Sable Bio in 2026.
What sectors does Turret Capital focus on?
Turret Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Energy & Sustainability, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Turret Capital focus on?
Turret Capital typically invests at the Early stage.
What is Turret Capital's AUM?
Turret Capital's assets under management are estimated between $35.0M and $35.0M.